Rice bioengineer Mario Escobar has won a Transformational Project Award from the American Heart Association to develop a new therapy for heart failure.

A new online platform, SMRT-Flames, can identify areas in need of land management in order to reduce future smoke exposures from uncontrolled fires. While most wildfire tools predict fire risk, SMRT-Flames explicitly considers smoke exposure across populations

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph’s Health Care London, are investigating whether Ambroxol - a cough medicine used safely for decades in Europe - can slow dementia in people with Parkinson’s disease. A new paper suggests Ambroxol can improve memory and psychiatric symptoms for people with Parkinson's disease.

An interdisciplinary George Mason University research team is breaking new ground in using artificial intelligence to support victims of interpersonal violence. Led by Kat Scafide and Janusz Wojtusiak of the College of Public Health and David Lattanzi of the College of Engineering and Computing, the Evidence-based AI Software for Injury Detection (EAS-ID) project has successfully completed Phase 1: development of a working prototype of a mobile app designed to accurately capture and document bruises. 

New research indicates that genetics may predict the effectiveness of anxiety and depression medications, potentially revolutionizing treatment approaches. Currently, nearly half of all patients don't respond to their initial prescription, leading to prolonged recovery. Researchers have developed a method using polygenic risk scores (PRS) from a simple genetic test to foresee which drugs will work best. While this technology has only been tested on genetic databases, clinical trials are anticipated. The goal is to develop an affordable and efficient test, allowing doctors to quickly select the most effective medication, thereby alleviating suffering much faster.